Handelsavisen
prelaunch
Companies Healthcare ALTHER.PA
AL
ALTHER.PA Euronext Paris Advanced Medical Equipment & Technology

Theraclion

€0,48
Open in Charts → Attach watcher ⌖
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-537,4 %
ROE
219,9 %
Net margin
-479,8 %
Debt / equity
-1,91
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Alther is a company in the Advanced Medical Equipment & Technology industry, specializing in the development and provision of advanced medical equipment and technology solutions.

Business. ALTHER.PA is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of medical products. The firm is headquartered in France and is listed on the Euronext Paris exchange under the ticker ALTHER.PA. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
219,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ALTHER.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ALTHER.PA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ALTHER.PA is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of medical products. The firm is headquartered in France and is listed on the Euronext Paris exchange under the ticker ALTHER.PA. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    Alther's capital structure is marked by a negative total equity of EUR -2,588,000 and a debt-to-equity ratio of -1.91, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.21, suggesting it has enough current assets to cover its current liabilities. However, the operating cash flow of EUR -7,159,000 and free cash flow of EUR -5,299,000 indicate a cash outflow from operations, which could pose liquidity challenges.

    In terms of profitability, Alther's return on equity is 2.1986, which is a positive figure but must be considered in the context of its negative equity. The return on assets is -0.4548, indicating that the company is not generating a positive return on its asset base. These metrics are below the industry norms for profitability and returns, suggesting that the company is underperforming relative to its peers.

    The company's revenue is concentrated in a single segment, as disclosed in its financials, with no specific geographic breakdown provided. This lack of diversification could expose the company to higher risks if the segment or region experiences a downturn.

    Alther's growth trajectory is currently negative, with a net income of EUR -5,690,000 and an operating income of EUR -6,373,000. The company's revenue of EUR 1,186,000 is not sufficient to cover its operating expenses, indicating a need for strategic adjustments to improve its financial performance.

    The risk assessment for Alther highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could affect its ability to meet short-term obligations. The dilution risk is low, as there is no indication of significant share issuance or dilution potential.

    Recent events and filings have not been disclosed in the provided data, so there is no specific information on recent developments that could impact the company's financial position or strategic direction.

    Key takeaways
    • Alther is experiencing significant financial losses, with a net income of EUR -5,690,000 and an operating income of EUR -6,373,000.
    • The company's capital structure is heavily reliant on debt, with a debt-to-equity ratio of -1.91.
    • Alther's return on assets is negative, indicating poor asset utilization and underperformance relative to industry standards.
    • The company's liquidity position is medium, with a current ratio of 2.21, but its negative operating and free cash flows could pose challenges.
    • There is a low dilution risk, but the company's net cash is negative after subtracting total debt, which could affect its ability to meet short-term obligations.
    • **margin_outlook_rationale**: The company's negative operating and net income suggest a deteriorating margin outlook driven by high operating expenses relative to revenue.
    • **rd_outlook_rationale**: No specific information is available to assess the outlook for research and development activities.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    €0,48
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -€2.6M
    Net cash
    -€1.6M
    Current ratio
    2.2
    Debt / equity
    -1.9
    ROA
    -45.5%
    ROE
    2.2%
    Cash conversion
    126.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-537,4 %Bottom quartile
    Net Margin-479,8 %Bottom quartile
    ROE219,9 %Best in class
    D/E-1,91Best in class
    Cash Conv1,26Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • ALTHER.PA Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Yann DuchesneExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ALTHER.PACanonical
    Euronext Paris · EUR

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage